Search results

• Active

  Phase II Clinical Trial Evaluating Cabozantinib and Pembrolizumab in Second-Line Therapy for Metastatic Pancreatic Adenocarcinoma

  Kim, J. (PI), Fan, W.-M. (CoI), Gao, M. (CoI), Higashi, R. (CoI), Rueckert, J. (CoI) & Qasem, S. (Former CoI)

  Exelixis Inc.

  12/15/21 → 6/7/25

  Project: Research project